BetterScholar BetterScholar
13
Title Level Year L/Y
Fecal calprotectin in inflammatory bowel disease
Natalie E Walsham, R. Sherwood
7 2016 7
2016
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
Wathsala S Nanayakkara, P. Skidmore, L. O'Brien, T. Wilkinson, R. Gearry
7 2016 7
2016
Postoperative pancreatic fistula: a review of traditional and emerging concepts
C. Nahm, S. Connor, J. Samra, A. Mittal
7 2018 7
2018
Interleukins in chronic liver disease: lessons learned from experimental mouse models
L. Hammerich, F. Tacke
6 2014 6
2014
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis
C. Payne, C. Bernstein, K. Dvorak, H. Bernstein
6 2008 6
2008
Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
G. Capurso, M. Traini, M. Piciucchi, M. Signoretti, P. Arcidiacono
6 2019 6
2019
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
M. Moré, A. Swidsinski
6 2015 6
2015
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states
D. Levitt, M. Levitt
6 2017 6
2017
A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease
T. Taft, L. Keefer
6 2016 6
2016
Bouveret syndrome: current management strategies
K. Caldwell, Seeyuen J. Lee, P. Leggett, K. Bajwa, Sheilendra S. Mehta, Shinil K. Shah
6 2018 6
2018
Iatrogenic bile duct injury: impact and management challenges
A. Pesce, S. Palmucci, G. La Greca, S. Puleo
6 2019 6
2019
Inflammatory bowel disease and anxiety: links, risks, and challenges faced
A. Bannaga, C. Selinger
6 2015 6
2015
Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
9 auth. S. Soldi, S. Vasileiadis, F. Uggeri, M. Campanale, L. Morelli, M. Fogli, ... F. Calanni, M. Grimaldi, A. Gasbarrini
6 2015 6
2015